Sarissa Capital Management LP Long-Term Concentrated

CIK: 0001577524 · Show all filings

Period: Q1 2023 (← Previous) (Next →)

Filing Date: May 15, 2023

Total Value ($000): $781,897 (100.0% shares, 0.0% debt)

Holdings (11)

ALKS ALKERMES PLC 32.3%

Value ($000) $252,713 Shares 8,964,640 Est. Cost $21.05 Unrealized +29.4%

BIIB BIOGEN INC 22.9%

Value ($000) $178,773 Shares 643,000 Est. Cost $278.12 Unrealized -0.5%

IRWD IRONWOOD PHARMACEUTICALS INC 22.1%

Value ($000) $172,423 Shares 16,390,000 Est. Cost $11.52 Unrealized -2.7%

INVA INNOVIVA INC 9.5%

Value ($000) $74,408 Shares 6,614,000 Est. Cost $13.07 Unrealized -7.2%

GILD GILEAD SCIENCES INC 9.0%

Value ($000) $70,525 Shares 850,000 Est. Cost $53.90 Unrealized +38.6%

— MERSANA THERAPEUTICS INC 2.0%

Value ($000) $15,618 Shares 3,800,000 Est. Cost $9.56 Unrealized —

— AMARIN CORP PLC 0.9%

Value ($000) $7,365 Shares 4,910,000 Est. Cost $3.92 Unrealized —

BCRX BIOCRYST PHARMACEUTICALS INC 0.8%

Value ($000) $6,464 Shares 775,000 Est. Cost $4.84 Unrealized +98.9%

— VOR BIOPHARMA INC 0.4%

Value ($000) $3,325 Shares 618,000 Est. Cost $43.10 Unrealized —

— REGULUS THERAPEUTICS INC 0.0%

Value ($000) $157 Shares 185,183 Est. Cost $2.07 Unrealized —

— PEAR THERAPEUTICS INC 0.0%

Value ($000) $128 Shares 500,356 Est. Cost $6.20 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ALKS	ALKERMES PLC	8,964,640	$252,713	32.3%	$21.05	+29.4%	SHS	G01767105
BIIB	BIOGEN INC	643,000	$178,773	22.9%	$278.12	-0.5%	COM	09062X103
IRWD	IRONWOOD PHARMACEUTICALS INC	16,390,000	$172,423	22.1%	$11.52	-2.7%	COM CL A	46333X108
INVA	INNOVIVA INC	6,614,000	$74,408	9.5%	$13.07	-7.2%	COM	45781M101
GILD	GILEAD SCIENCES INC	850,000	$70,525	9.0%	$53.90	+38.6%	COM	375558103
—	MERSANA THERAPEUTICS INC	3,800,000	$15,618	2.0%	$9.56	—	COM	59045L106
—	AMARIN CORP PLC	4,910,000	$7,365	0.9%	$3.92	—	SPONS ADR NEW	023111206
BCRX	BIOCRYST PHARMACEUTICALS INC	775,000	$6,464	0.8%	$4.84	+98.9%	COM	09058V103
—	VOR BIOPHARMA INC	618,000	$3,325	0.4%	$43.10	—	COM	929033108
—	REGULUS THERAPEUTICS INC	185,183	$157	0.0%	$2.07	—	COM	75915K309
—	PEAR THERAPEUTICS INC	500,356	$128	0.0%	$6.20	—	CLASS A COM	704723105